The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.

@article{Pitt1999TheEO,
  title={The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.},
  author={B. Pitt and F. Zannad and W. Remme and R. Cody and A. Castaigne and A. Perez and J. Palensky and J. Wittes},
  journal={The New England journal of medicine},
  year={1999},
  volume={341 10},
  pages={
          709-17
        }
}
  • B. Pitt, F. Zannad, +5 authors J. Wittes
  • Published 1999
  • Medicine
  • The New England journal of medicine
  • BACKGROUND AND METHODS Aldosterone is important in the pathophysiology of heart failure. In a doubleblind study, we enrolled 1663 patients who had severe heart failure and a left ventricular ejection fraction of no more than 35 percent and who were being treated with an angiotensin-converting-enzyme inhibitor, a loop diuretic, and in most cases digoxin. A total of 822 patients were randomly assigned to receive 25 mg of spironolactone daily, and 841 to receive placebo. The primary end point was… CONTINUE READING
    6,992 Citations

    Paper Mentions

    Interventional Clinical Trial
    The purpose of this study is to determine if patients who receive an early radiofrequency ablation will have fewer hospitalizations, unplanned office visits, and emergency room visits… Expand
    ConditionsHeart Failure With Preserved Ejection Fraction
    InterventionProcedure
    Interventional Clinical Trial
    Hypertrophic Cardiomyopathy (HCM) is the most common hereditary heart disease with high mortality. Heart failure is the most common complication (about 50% incidence) in these… Expand
    ConditionsFibrosis, Hypertrophic Cardiomyopathy
    InterventionDrug
    Blog Post
    Interventional Clinical Trial
    In stage 3 chronic kidney disease (CKD) the risk of death due to cardiovascular causes is high and greatly exceeds the risk of progression to end stage renal failure. This high… Expand
    ConditionsCardio-Renal Syndrome, Renal Insufficiency, Chronic
    InterventionDrug
    Effectiveness and safety of spironolactone for systolic heart failure.
    • 13
    Spironolactone for heart failure with preserved ejection fraction.
    • 915
    • PDF
    Usefulness of spironolactone in a specialized heart failure clinic.
    • 28

    References

    SHOWING 1-10 OF 41 REFERENCES
    The effect of digoxin on mortality and morbidity in patients with heart failure.
    • 2,223
    • PDF
    Efficacy and tolerance of spironolactone in essential hypertension.
    • 231
    Captopril in heart failure. A double blind controlled trial.
    • 378
    • PDF